Efficiency of Art-therapy in Psychotic Disorders

October 18, 2019 updated by: University Hospital, Strasbourg, France
The main purpose of the protocol is to test the efficiency of art-therapy versus metacognitive rehabilitation on the visual perception disorders observed in patients with schizophrenia.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

9

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Strasbourg, France, 67091
        • Service de psychiatrie, Hôpitaux Universitaires de Strasbourg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 53 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • schizophrenia according to DSM IV

Exclusion Criteria:

  • addiction problem
  • invalidating visual sensory problems
  • neurological history

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Art-therapy
16 Art-therapy sessions
Behavioral: Art therapy
Active Comparator: Metacognitive therapy
16 Metacognitive therapy sessions
Behavioral: metacognitive therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in Response times between baseline and after 16 therapy sessions
Time Frame: Baseline and after 16 therapy sessions (up to 6 months)
Baseline and after 16 therapy sessions (up to 6 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Clinical scales (SAPS and SANS) between baseline and after 16 therapy sessions
Time Frame: Baseline and after 16 therapy sessions (up to 6 months)
Baseline and after 16 therapy sessions (up to 6 months)
Change in esthetic perception between baseline and after 16 therapy sessions
Time Frame: Baseline and after 16 therapy sessions (up to 6 months)
Esthetic Perception Test
Baseline and after 16 therapy sessions (up to 6 months)
Change in errors in visual organization tasks between baseline and after 16 therapy sessions
Time Frame: aseline and after 16 therapy sessions (up to 6 months)
aseline and after 16 therapy sessions (up to 6 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Strasbourg, France

Investigators

  • Principal Investigator: Anne GIERSCH, PhD, Hôpitaux Universitaires de Strasbourg

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 27, 2015

Primary Completion (Actual)

October 1, 2019

Study Completion (Actual)

October 1, 2019

Study Registration Dates

First Submitted

January 26, 2015

First Submitted That Met QC Criteria

March 3, 2015

First Posted (Estimate)

March 9, 2015

Study Record Updates

Last Update Posted (Actual)

October 21, 2019

Last Update Submitted That Met QC Criteria

October 18, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 5937

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophrenia

Clinical Trials on Art therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe